Hikma Pharmaceutical | HIK - Equity Capital And Reserves

Stock Price
1,395.50
Daily Change
-256.50 -15.53%
Monthly
-9.68%
Yearly
-36.04%
Q1 Forecast
1,600.34

Hikma Pharmaceutical reported $2.55B in Equity Capital and Reserves for its fiscal semester ending in June of 2025.





Equity Capital And Reserves Change Date
Almirall EUR 1.49B 24.03M Dec/2025
argenx SE USD 6.1B 597.47M Jun/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
Autolus Therapeutics Ltd USD 265.45M 81.01M Sep/2025
Bayer EUR 29.7B 799M Sep/2025
Fresenius EUR 18.62B 320M Sep/2025
Galapagos EUR 2.45B 196.86M Sep/2025
Genmab DKK 5.3B 6M Jun/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
GRIFOLS EUR 5.18B 2.42B Sep/2025
Hikma Pharmaceutical USD 2.55B 230M Jun/2025
Lonza CHF 9.33B 23M Dec/2024
Merck EUR 28.94B 677M Sep/2025
Orion EUR 1.28B 265.4M Dec/2025
Recordati EUR 1.93B 57.32M Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 71.71B 1.55B Dec/2025
UCB EUR 10.03B 1.08B Dec/2024